BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1256 related articles for article (PubMed ID: 26759139)

  • 1. Similar in vitro maturation rates of oocytes retrieved during the follicular or luteal phase offer flexible options for urgent fertility preservation in breast cancer patients.
    Grynberg M; Poulain M; le Parco S; Sifer C; Fanchin R; Frydman N
    Hum Reprod; 2016 Mar; 31(3):623-9. PubMed ID: 26759139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. What threshold values of antral follicle count and serum AMH levels should be considered for oocyte cryopreservation after in vitro maturation?
    Sonigo C; Simon C; Boubaya M; Benoit A; Sifer C; Sermondade N; Grynberg M
    Hum Reprod; 2016 Jul; 31(7):1493-500. PubMed ID: 27165625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of breast cancer prognostic factors on oocyte in vitro maturation outcomes performed for urgent fertility preservation.
    Raad J; Sonigo C; Benoit A; Cedrin-Durnerin I; Sifer C; Sermondade N; Grynberg M
    Hum Reprod; 2022 Jun; 37(7):1480-1488. PubMed ID: 35586947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cryopreservation of in vitro matured oocytes in addition to ovarian tissue freezing for fertility preservation in paediatric female cancer patients before and after cancer therapy.
    Abir R; Ben-Aharon I; Garor R; Yaniv I; Ash S; Stemmer SM; Ben-Haroush A; Freud E; Kravarusic D; Sapir O; Fisch B
    Hum Reprod; 2016 Apr; 31(4):750-62. PubMed ID: 26848188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immature oocyte retrieval and in vitro oocyte maturation at different phases of the menstrual cycle in women with cancer who require urgent gonadotoxic treatment.
    Creux H; Monnier P; Son WY; Tulandi T; Buckett W
    Fertil Steril; 2017 Jan; 107(1):198-204. PubMed ID: 27810160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BRCA1/2 gene mutations do not affect the capacity of oocytes from breast cancer candidates for fertility preservation to mature in vitro.
    Grynberg M; Dagher Hayeck B; Papanikolaou EG; Sifer C; Sermondade N; Sonigo C
    Hum Reprod; 2019 Feb; 34(2):374-379. PubMed ID: 30561604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum antimüllerian hormone is associated with the number of oocytes matured in vitro and with primordial follicle density in candidates for fertility preservation.
    Sermondade N; Sonigo C; Sifer C; Valtat S; Ziol M; Eustache F; Grynberg M
    Fertil Steril; 2019 Feb; 111(2):357-362. PubMed ID: 30527837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combining fertility preservation procedures to spread the eggs across different baskets: a feasibility study.
    Delattre S; Segers I; Van Moer E; Drakopoulos P; Mateizel I; Enghels L; Tournaye H; De Vos M
    Hum Reprod; 2020 Nov; 35(11):2524-2536. PubMed ID: 32951035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FGF2, LIF, and IGF1 (FLI) supplementation during human in vitro maturation enhances markers of gamete competence.
    Amargant F; Zhou LT; Yuan Y; Nahar A; Krisher RL; Spate LD; Roberts RM; Prather RS; Rowell EE; Laronda MM; Duncan FE
    Hum Reprod; 2023 Oct; 38(10):1938-1951. PubMed ID: 37608600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Live births following fertility preservation using in-vitro maturation of ovarian tissue oocytes.
    Segers I; Bardhi E; Mateizel I; Van Moer E; Schots R; Verheyen G; Tournaye H; De Vos M
    Hum Reprod; 2020 Sep; 35(9):2026-2036. PubMed ID: 32829388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An improved IVM method for cumulus-oocyte complexes from small follicles in polycystic ovary syndrome patients enhances oocyte competence and embryo yield.
    Sánchez F; Lolicato F; Romero S; De Vos M; Van Ranst H; Verheyen G; Anckaert E; Smitz JEJ
    Hum Reprod; 2017 Oct; 32(10):2056-2068. PubMed ID: 28938744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human cumulus-enclosed germinal vesicle oocytes from early antral follicles reveal heterogeneous cellular and molecular features associated with in vitro maturation capacity.
    Sánchez F; Romero S; De Vos M; Verheyen G; Smitz J
    Hum Reprod; 2015 Jun; 30(6):1396-409. PubMed ID: 25904637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human-induced pluripotent stem cell-derived ovarian support cell co-culture improves oocyte maturation in vitro after abbreviated gonadotropin stimulation.
    Piechota S; Marchante M; Giovannini A; Paulsen B; Potts KS; Rockwell G; Aschenberger C; Noblett AD; Figueroa AB; Sanchez M; Barrachina F; Wiemer K; Guzman L; Belchin P; Pierson Smela M; Fortuna PRJ; Chatterjee P; Tran ND; Kelk DA; Forti M; Marcinyshyn S; Smith T; McCulloh DH; Fernandez-Gonzalez MJ; Abittan B; Ortiz S; Klein JU; Klatsky P; Ordonez-Perez D; Kramme CC
    Hum Reprod; 2023 Dec; 38(12):2456-2469. PubMed ID: 37815487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progesterone levels in letrozole associated controlled ovarian stimulation for fertility preservation in breast cancer patients.
    Goldrat O; Gervy C; Englert Y; Delbaere A; Demeestere I
    Hum Reprod; 2015 Sep; 30(9):2184-9. PubMed ID: 26109617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prior exposure to chemotherapy does not reduce the in vitro maturation potential of oocytes obtained from ovarian cortex in cancer patients.
    Karavani G; Vedder K; Gutman-Ido E; Gruda Sussman R; Goldschmidt N; Mordechai-Daniel T; Ben-Meir A; Imbar T
    Hum Reprod; 2023 Sep; 38(9):1705-1713. PubMed ID: 37414543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heparin and cAMP modulators interact during pre-in vitro maturation to affect mouse and human oocyte meiosis and developmental competence.
    Zeng HT; Ren Z; Guzman L; Wang X; Sutton-McDowall ML; Ritter LJ; De Vos M; Smitz J; Thompson JG; Gilchrist RB
    Hum Reprod; 2013 Jun; 28(6):1536-45. PubMed ID: 23559189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimizing human oocyte cryopreservation for fertility preservation patients: should we mature then freeze or freeze then mature?
    Lee JA; Barritt J; Moschini RM; Slifkin RE; Copperman AB
    Fertil Steril; 2013 Apr; 99(5):1356-62. PubMed ID: 23266213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro maturation of human immature oocytes for fertility preservation.
    Chian RC; Uzelac PS; Nargund G
    Fertil Steril; 2013 Apr; 99(5):1173-81. PubMed ID: 23433515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancing the scope of in vitro maturation for fertility preservation: transvaginal retrieval of immature oocytes during endoscopic gynaecological procedures.
    Song XL; Lu CL; Zheng XY; Nisenblat V; Zhen XM; Yang R; Li M; Li R; Yuan YF; Ma CH; Liu P; Feng HL; Yan J; Qiao J
    Hum Reprod; 2020 Apr; 35(4):837-846. PubMed ID: 32154563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro oocyte maturation and preantral follicle culture from the luteal-phase baboon ovary produce mature oocytes.
    Xu M; Fazleabas AT; Shikanov A; Jackson E; Barrett SL; Hirshfeld-Cytron J; Kiesewetter SE; Shea LD; Woodruff TK
    Biol Reprod; 2011 Apr; 84(4):689-97. PubMed ID: 21123815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 63.